-LCB-_-LRB-
Effect_NN
of_IN
antihypertensive_JJ
therapy_NN
with_IN
captopril_NN
on_IN
gluco_NN
-_:
and_CC
mineralocorticoid_NN
receptors_NNS
of_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
in_IN
hypertensive_JJ
patients_NNS
of_IN
various_JJ
age_NN
-RCB-_-RRB-

Binding_NN
of_IN
3H-dexamethasone_NN
and_CC
3H-aldosterone_NN
by_IN
peripheral_JJ
lymphocyte_NN
receptors_NNS
was_VBD
investigated_VBN
in_IN
healthy_JJ
persons_NNS
and_CC
hypertensive_JJ
patients_NNS
before_IN
and_CC
after_IN
2-week_JJ
captopril_NN
treatment_NN
._.

The_DT
number_NN
of_IN
glucocorticoid_NN
and_CC
mineralocorticoid_NN
binding_NN
sites_NNS
was_VBD
increased_VBN
in_IN
hypertensives_NNS
vs_CC
normotensives_NNS
._.

The_DT
treatment_NN
with_IN
the_DT
ACE_NN
inhibitor_NN
captopril_NN
led_VBD
to_TO
activation_NN
of_IN
hormone-receptor_NN
interactions_NNS
._.

There_EX
was_VBD
a_DT
more_RBR
marked_JJ
rise_NN
of_IN
the_DT
number_NN
of_IN
receptors_NNS
in_IN
middle-aged_JJ
-LRB-_-LRB-
44-55_CD
years_NNS
-RRB-_-RRB-
hypertensives_NNS
vs_CC
elderly_JJ
-LRB-_-LRB-
61-80_CD
years_NNS
-RRB-_-RRB-
subjects_NNS
after_IN
captopril_NN
treatment_NN
._.

